phrma logo

PhRMA

PhRMA Sites

Login

Explore Member-Only Resources

Access exclusive advocacy, policy, and research materials through the member site.

Login now

About

About

Our Agenda

Our Agenda

Policy Issues

We believe that patients should have access to innovative medicines.

Learn More

Innovation Ecosystem

Intellectual Property

Research & Development

Future of Medicine

Government Price Setting

International

Innovation Ecosystem

Patient Access & Affordability

PBMs & Middlemen

Hospitals and 340B

Insurance Coverage

Cost of Medicines

Medicare & Medicaid

Patient Access & Affordability

Resources

Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies.

Learn More

Resources

Resources

Newsroom

Newsroom

Blog

Blog

America's Medicines

PhRMA Foundation

PhRMA Foundation Logo

Voters for Cures

VotersForCures.org Logo

Working for Cures

workersforcures.org logo

This is Innovation

Innovation.org logo

View More

Search in PhRMA

Find resources, news, and articles related to policy issues and scientific innovation.

What are you looking for?

Most Recent

Policy Paper

Press

Blog

Report

Fact Sheet

Event

Resource

Pages

Leader

Author

Comment

not used title

not used title

A survey of more than 5,000 Americans conducted with Ipsos found that nearly 40% of insured Americans struggle to understand what their health insurance covers.

The new data come from the third installment of the Patient Experience Survey and reveal how insurers and middlemen like pharmacy benefit managers (PBMs) impose barriers and cost sharing practices that stand between patients and their medicines.

Here are three key findings, along with examples from patients in their own words, from the latest PES report.

1. Patients are concerned about insurer- and PBM-imposed barriers, such as formulary exclusions, prior authorization and other practices.

Nearly half (47%) of insured Americans taking prescription medicine are concerned that a medicine their doctor recommended or prescribed wouldn’t be covered by their insurer (i.e., excluded from the formulary). Additionally, 42% are concerned that they would have to wait for their insurer to provide prior authorization for a medicine their doctor prescribed.

Angelitha

2. Health insurance coverage is confusing for many insured Americans.

Thirty-nine percent of insured Americans say they do not understand what their health insurance covers, and 35% say they have trouble navigating their insurance coverage. Difficulty navigating health insurance rings especially true for those who say they are in poor health (42%).

Jim

3. Navigating, understanding and anticipating health insurance coverage is a challenge.

One in five (22%) insured Americans say they have trouble navigating, understanding and anticipating their health insurance. Those with high deductible health plans (27%) and those who switched their health insurance plans within the past year (28%) are particularly affected.

Gus

To address these challenges, insured Americans favor policy solutions that improve their ability to navigate and access their care by seeking to remove barriers imposed by insurers and middlemen such as PBMs. Such solutions could lower out-of-pocket costs and simplify the health coverage process for insured Americans. To learn more about challenges Americans face as they navigate the health system and solutions that seek to alleviate these challenges, visit PhRMA.org/Middlemen.

+++

PhRMA’s Patient Experience Survey (PES) is a research initiative to explore the challenges Americans face as they navigate the health care system. The poll was conducted among 5,103 American adults (age 18 or older), including 4,720 with insurance, from May 23 – June 1, 2022, using Ipsos’ probability-based KnowledgePanel®, and it is representative of the American adult population. The margin of sampling error is plus or minus 1.5 percentage points at the 95% confidence level, for results based on the entire sample of adults. The latest PES also features qualitative data from hours of in-depth interviews.

Tom Wilbur

Tom Wilbur is Deputy Vice President of Public Affairs at PhRMA where he leads the state public affairs team and Voters for Cures, PhRMA’s grassroots advocacy initiative. Prior to joining PhRMA in 2019, Tom served as a senior aide on Capitol Hill for U.S. Rep. Fred Upton and the House Energy and Commerce Committee. Tom holds an M.A. in strategic communications from Michigan State University and a B.A. in social science and history from Central Michigan University. He enjoys spending time with family and friends, volunteering, reading and golfing.

Author Twitter

Author LinkedIn

What AARP isn’t telling seniors about MFN

August 24, 2026

Policymakers should improve patient access and reject price controls

August 18, 2026

Insurers blame GLP-1s for rising costs. The data tells a different story.

August 14, 2026

The FTC’s PBM enforcement actions gave us a glimpse behind the curtain; it’s time to let the light in.

August 7, 2026

In their own words: Insured Americans struggle to navigate complex coverage

Health Insurance

Out-of-Pocket Costs

PBMs/Insurance

Polling

In their own words: Insured Americans struggle to navigate complex coverage

October 26, 2022

In their own words: Insured Americans struggle to navigate complex coverage

Stay current on policy making

Sign up for email updates and follow us on social. 

About

Our Agenda

Policy Issues

Resources

Blog

Contact Us

Privacy Policy

Terms of Service

Facebook

Facebook

X

Twitter X

LinkedIn

LinkedIn

Instagram

instagram logo

America's Medicines

PhRMA Foundation

Voters for Cures

Working for Cures

Innovation.org

Please type your email

Success!

You've been added to the list